As of March 2026 , the FDA reviewed available data and found no increased risk of suicidal thoughts or behaviors in people taking GLP-1s
Finally, regarding the results of anthropometric measurements, the present study showed significant increase in weight z-score and height z-score with non-significant change in BMI z-score after 3 months of KD initiation
These kits ensure high sensitivity and reproducibility, facilitating pharmacokinetic studies, drug efficacy assessments, and therapeutic drug monitoring
Description: Fitaro, with its Semaglutide content, belongs to the GLP-1 receptor agonist class, renowned for its multifaceted benefits in diabetes care
In patients with chronic cerebrovascular insufficiency, treatment with Semax has shown significant clinical improvement, stabilization of disease progression, and a reduction in the risk of stroke and transient ischemic attacks (Gusev et al., Zh Nevrol Psikhiatr 2005)